BREAST CANCERLeader: Eric Winer, MD617-632-3800 ewiner@partners.org

Co-Leader: Leif Ellisen, MD, PhD 617-726-4315 lellisen@mgh.harvard.edu

Co-Leader: Stuart Schnitt, MD617-667-4344 sschnitt@bidmc.harvard.edu

Co-Leader: Rulla Tamimi, ScD617-525-0862 rulla.tamimi@channing.harvard.edu

Co-Leader: Jean Zhao, PhD617-632-2932 jean_zhao@dfci.harvard.edu

CANCER CARE DELIVERY RESEARCHLeader: Deborah Schrag, MD, MPH 617-582-8301 deb_schrag@dfci.harvard.edu

Co-Leader: Nancy Keating, MD, MPH 617-432-3093 keating@hcp.med.harvard.edu

Co-Leader: Jennifer Temel, MD617-724-4000 jtemel@partners.org

Leader: Franziska Michor, PhD617-632-5045 michor@jimmy.harvard.edu

CANCER DATA SCIENCES

CANCER CELL BIOLOGY

Co-Leader: Xihong Lin, PhD617-432-2914 xlin@hsph.harvard.edu

Co-Leader: Peter Park, PhD617-432-7373 peter_park@harvard.edu

Leader: Lorelei Mucci, MPH, ScD617-432-1732 lmucci@hsph.harvard.edu

CANCER EPIDEMIOLOGYCo-Leader: Meir Stampfer, MD, DrPH617-525-2749 mstampfe@hsph.harvard.edu

Leader: David Kwiatkowski, MD, PhD617-355-9005 dk@rics.bwh.harvard.edu

CANCER GENETICS

DF/HCC is home to seventeen transdisciplinary research programs that prioritize and facilitate the collaboration of 1,100 members from five academic medical institutions and two Harvard health science schools. Many programs have

representation across the translational-, basic-, clinical-, and population-based sciences.

Co-Leader: Wade Harper, PhD617-432-6590 wade_harper@hms.harvard.edu

Co-Leader: Anders Naar, PhD617-724-7942 naar@helix.mgh.harvard.edu

Co-Leader: Kornelia Polyak, MD, PhD617-632-2106 kornelia_polyak@dfci.harvard.edu

Co-Leader: Gad Getz, PhD617-714-7621gadgetz@broadinstitute.org

Leader: Arlene Sharpe, MD, PhD617-432-6568 arlene_sharpe@hms.harvard.edu

Co-Leader: Kai Wucherpfennig, MD, PhD617-632-3086 kai_wucherpfennig@dfci.harvard.edu

CANCER IMMUNOLOGY

Program Leaders

Program Leaders continued

Leader: Donald Kufe, MD 617-632-3141 donald_kufe@dfci.harvard.edu

Co-Leader: Bruce Chabner, MD 617-724-3200 bchabner@partners.org

DEVELOPMENTAL THERAPEUTICS

GASTROINTESTINAL MALIGNANCIESCo-Leader: Robert Mayer, MD617-632-3474 robert_mayer@dfci.harvard.edu

Co-Leader: Kenneth Tanabe, MD617-724-3868 ktanabe@partners.org

Co-Leader: Keith Flaherty, MD617-724-4800 kflaherty@partners.org

Co-Leader: Geoffrey Shapiro, MD, PhD 617-632-4942 geoffrey_shapiro@dfci.harvard.edu

KIDNEY CANCERLeader: David McDermott, MD617-632-2100 dmcdermo@bidmc.harvard.edu

Co-Leader: Toni Choueiri, MD617-632-5456 toni_choueiri@dfci.harvard.edu

Co-Leader: Othon Iliopoulos, MD617-724-3404 iliopoul@helix.mgh.harvard.edu

Co-Leader: William Kaelin Jr., MD617-632-3975 william_kaelin@dfci.harvard.edu

Co-Leader: M. D. Michaelson, MD, PhD617-726-1594 dmichaelson1@partners.org

LEUKEMIA

Co-Leader: Sabina Signoretti, MD617-525-7437 ssignoretti@partners.org

Leader: Benjamin Ebert, MD, PhD617-355-9091 benjamin_ebert@dfci.harvard.edu

Co-Leader: Timothy Graubert, MD617-643-0670 tgraubert@partners.org

Co-Leader: A. T. Look, MD617-632-5826 thomas_look@dfci.harvard.edu

Co-Leader: Pier Paolo Pandolfi, MD, PhD617-735-2121 ppandolf@bidmc.harvard.edu

Co-Leader: Kimberly Stegmaier, MD617-632-4438 kimberly_stegmaier@dfci.harvard.edu

Co-Leader: Richard Stone, MD617-632-2214 rstone@partners.org

Leader: Ramesh Shivdasani, MD, PhD617-632-5746 ramesh_shivdasani@dfci.harvard.edu

Co-Leader: Theodore Hong, MD617-724-1159 tshong1@partners.org

Leader: Bruce Johnson, MD 617-632-5314 bejohnson@partners.org

Leader: David Christiani, MD, MPH 617-432-3323 dchris@hsph.harvard.edu

Co-Leader: Daniel Costa, MD, PhD 617-667-9236 dbcosta@bidmc.harvard.edu

LUNG CANCER

Co-Leader: Pasi Janne, MD, PhD 617-632-6076 pjanne@partners.org

Co-Leader: Alice Shaw, MD, PhD617-724-4000 ashaw1@partners.org

Leader: Vish Viswanath, PhD617-632-2225 vish_viswanath@dfci.harvard.edu

Co-Leader: A. Lindsay Frazier, MD617-632-2273 lindsay_frazier@dfci.harvard.edu

Co-Leader: David R. Williams, MPH, PhD617-432-6807 dwilliam@hsph.harvard.edu

CANCER RISK AND DISPARITIES

About DF/HCCDana-Farber/Harvard Cancer Center is the largest National Cancer Institute-designated Comprehensive Cancer Center in the nation. Founded in 1998, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard-affiliated community. The primary goal of the Cancer Center is to encourage and promote collaborative interactions and translational research that will lead to new approaches to cancer prevention, diagnosis, and treatment.

Program Leaders continued

for more information

For general information about DF/HCC’s Research Programs, visit:

dfhcc.harvard.edu/programs

Co-Leader: David E. Fisher, MD, PhD617-643-5428 dfisher3@partners.org

Co-Leader: Tracy Batchelor, MD, MPH617-617-8770 tbatchelor@partners.org

Co-Leader: Charles Stiles, PhD617-632-3512 charles_stiles@dfci.harvard.edu

Co-Leader: Massimo Loda, MD617-632-4001 massimo_loda@dfci.harvard.edu

NEURO-ONCOLOGY

PROSTATE CANCERCo-Leader: Steven Balk, MD, PhD 617-735-2065 sbalk@bidmc.harvard.edu

Co-Leader: Adam Kibel, MD617-732-6665 akibel@partners.org

Co-Leader: Matthew Smith, MD, PhD617-724-5257 mrsmith@partners.org

MELANOMACo-Leader: F. Stephen Hodi, MD617-632-5053 stephen_hodi@dfci.harvard.edu

Co-Leader: Christopher Sweeney, MBBS617-632-4524 csweeney2@partners.org

Leader: Margaret Shipp, MD 617-632-3874 margaret_shipp@dfci.harvard.edu

Co-Leader: Kenneth Anderson, MD 617-632-2144 kenneth_anderson@dfci.harvard.edu

LYMPHOMA AND MYELOMACo-Leader: Jon Aster, MD, PhD 617-525-4406 jaster@partners.org